Toxoplasma gondii, Molecular Detection, PCR
PPP2R2B (Protein Phosphatase 2 Regulatory Subunit Beta) Gene Mutation Analysis
Alpha Fetoprotein (AFP), Spinal Fluid
Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Herpes Simplex Virus (HSV) 1 and 2 IgG
MDM2 Gene Amplification, FISH
Neisseria gonorrhoeae Nucleic Acid, Liquid Cytology
Fibrinogen Antigen
Amyloid Beta Protein Ratio 1-42/1-40, Spinal Fluid
RTEL1 Gene Mutation Analysis
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test
Turnaround Time
Access to
Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
is restricted.
Sign up now
Loading...